Vivos Therapeutics' SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea Seite 1
14.06.2022 - Study Recently Presented at the SLEEP 2022 Annual MeetingLITTLETON, Colo., June 14, 2022 (GLOBE NEWSWIRE) - Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or “the Company”), a revenue-generating medical technology company focused on developing ... Seite 1
Source: wallstreet-online.de